Response to Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69-76

Affiliations

• ¹ Department of Endocrinology and Diabetes, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia.
• ² Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, Queensland, Australia.
• ³ University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, Queensland, Australia.
• ⁴ Faculty of Medicine, University of Queensland, Herston, Queensland, Australia.
• ⁵ Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
• ⁶ School of Pharmacy, University of Queensland, Woolloongabba, Queensland, Australia.
• ⁷ Department of Diabetes and Endocrinology, Perth Children's Hospital, Perth, Western Australia, Australia.
• ⁸ Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
• ⁹ School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia.
• ¹⁰ Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, Queensland, Australia emma.duncan@qut.edu.au.
• ¹¹ Department of Endocrinology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.